<DOC>
	<DOCNO>NCT02719314</DOCNO>
	<brief_summary>Glucocorticoids remain among important frequently use anti-inflammatory immunosuppressive immune-modulatory act drug treat rheumatic ( ) diseases . Unfortunately , glucocorticoid also exert undesired effect , especially high dosage give long period time . The available data describe frequency severity adverse effect fragmentary . This statement especially true glucocorticoid-induced osteoporosis ( GIOP ) context chronic inflammatory rheumatic disease ( part ) psoriasis ( arthritis ) . The state knowledge scientific data , sparse , partly conflict often derive over-aged project study . Therefore , urgent need work various current question systematically high scientific level possible . In order address need , aim collect analyze disease- bone-related data patient chronic inflammatory rheumatic disease psoriasis therapy glucocorticoid , build respective GIOP-Databank . Patients attend diagnostics , necessary therapy follow-up GIOP , accord current guideline . Clinical , laboratory instrumental examination result 1000 patient first three year project plan documented prospective database .</brief_summary>
	<brief_title>Glucocorticoid-induced Osteoporosis Patients With Chronic Inflammatory Rheumatic Diseases Psoriasis</brief_title>
	<detailed_description>Glucocorticoids remain among important frequently use anti-inflammatory immunosuppressive immune-modulatory act drug treat rheumatic ( ) diseases . Unfortunately , glucocorticoid also exert undesired effect , especially high dosage give long period time . The available data describe frequency severity adverse effect fragmentary . This statement especially true glucocorticoid-induced osteoporosis ( GIOP ) context chronic inflammatory rheumatic disease ( part ) psoriasis ( arthritis ) , since GIOP count among two important adverse effect glucocorticoid therapy , rheumatologists patient . The state knowledge scientific data , sparse , partly conflict often derive over-aged project study . Therefore , urgent need work various current question systematically high scientific level possible . In order address need , aim collect analyze disease- bone-related data patient chronic inflammatory rheumatic disease psoriasis therapy glucocorticoid , build respective GIOP-Databank . Patients attend diagnostics , necessary therapy follow-up GIOP , accord current guideline . Clinical , laboratory instrumental examination result 1000 patient first three year project plan documented prospective database .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<criteria>Every patient fulfill follow inclusion criterion : patient ( control group : without ) diagnosis chronic inflammatory rheumatic disease psoriasis patient ( control group ) have/had already glucocorticoid therapy , patient implementation new longterm GC therapy expect patient , accord Dachverband Osteologie ( DVO , Germany ) guideline , attend osteoporosis bone metabolism outpatient consultation hour refer hospital ward Charit√© diagnosis , treatment followup capability understand patient information consent participation project storage data If following exclusion criterion true , patient must include study : alcohol , medication and/or drug addiction severe psychiatric disease limit comprehension project plan study protocol ( person incapable give informed consent ) pregnant lactate patient patient incapable give informed consent reason prisoner person committed institution due official judicial order</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>